These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30097873)

  • 1. A Simple, Sensitive, and Generalizable Plate Assay for Screening PARP Inhibitors.
    Kirby IT; Morgan RK; Cohen MS
    Methods Mol Biol; 2018; 1813():245-252. PubMed ID: 30097873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.
    Wigle TJ; Church WD; Majer CR; Swinger KK; Aybar D; Schenkel LB; Vasbinder MM; Brendes A; Beck C; Prahm M; Wegener D; Chang P; Kuntz KW
    SLAS Discov; 2020 Mar; 25(3):241-252. PubMed ID: 31855104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule Screening Assay for Mono-ADP-Ribosyltransferases.
    Haikarainen T; Murthy S; Maksimainen MM; Lehtiö L
    Methods Mol Biol; 2018; 1813():237-244. PubMed ID: 30097872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
    Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
    Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
    Carter-O'Connell I; Cohen MS
    Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Genomic Sites of ADP-Ribosylation Mediated by Specific Nuclear PARP Enzymes Using Click-ChIP.
    Rogge RA; Gibson BA; Kraus WL
    Methods Mol Biol; 2018; 1813():371-387. PubMed ID: 30097881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical genetic methodologies for identifying protein substrates of PARPs.
    Rodriguez KM; Cohen MS
    Trends Biochem Sci; 2022 May; 47(5):390-402. PubMed ID: 34366182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics.
    Li N; Wang Y; Deng W; Lin SH
    Anticancer Agents Med Chem; 2019; 19(2):206-212. PubMed ID: 30417796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics.
    Kirby IT; Cohen MS
    Curr Top Microbiol Immunol; 2019; 420():211-231. PubMed ID: 30242511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Clickable NAD
    Zhang L; Lin H
    Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors.
    Venkannagari H; Fallarero A; Feijs KL; Lüscher B; Lehtiö L
    Eur J Pharm Sci; 2013 May; 49(2):148-56. PubMed ID: 23485441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a "Clickable" NAD
    Gibson BA; Kraus WL
    Methods Mol Biol; 2017; 1608():111-135. PubMed ID: 28695507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs.
    Maksimainen MM; Murthy S; Sowa ST; Galera-Prat A; Rolina E; Heiskanen JP; Lehtiö L
    Bioorg Med Chem; 2021 Dec; 52():116511. PubMed ID: 34801828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of the catalytic domain of human PARP15 in complex with small molecule inhibitors.
    Zhou X; Yang Y; Xu Q; Zhou H; Zhong F; Deng J; Zhang J; Li J
    Biochem Biophys Res Commun; 2022 Sep; 622():93-100. PubMed ID: 35843099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Microarray Based Discovery of PARP14 Inhibitors.
    Peng B; Thorsell AG; Karlberg T; Schüler H; Yao SQ
    Angew Chem Int Ed Engl; 2017 Jan; 56(1):248-253. PubMed ID: 27918638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADP
    Bian C; Zhang C; Luo T; Vyas A; Chen SH; Liu C; Kassab MA; Yang Y; Kong M; Yu X
    Nat Commun; 2019 Feb; 10(1):693. PubMed ID: 30741937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity.
    Kirby IT; Kojic A; Arnold MR; Thorsell AG; Karlberg T; Vermehren-Schmaedick A; Sreenivasan R; Schultz C; Schüler H; Cohen MS
    Cell Chem Biol; 2018 Dec; 25(12):1547-1553.e12. PubMed ID: 30344052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards small molecule inhibitors of mono-ADP-ribosyltransferases.
    Ekblad T; Lindgren AE; Andersson CD; Caraballo R; Thorsell AG; Karlberg T; Spjut S; Linusson A; Schüler H; Elofsson M
    Eur J Med Chem; 2015 May; 95():546-51. PubMed ID: 25847771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting Protein ADP-Ribosylation Using a Clickable Aminooxy Probe.
    Morgan RK; Cohen MS
    Methods Mol Biol; 2017; 1608():71-77. PubMed ID: 28695504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PASTA: PARP activity screening and inhibitor testing assay.
    Kirby IT; Sanderson DJ; Cohen MS
    STAR Protoc; 2021 Mar; 2(1):100344. PubMed ID: 33665624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.